Defense Mechanisms of Neoplastic Cells against Chemical Stress
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 4090
Special Issue Editors
Interests: MDR in leukemia; ABC transporters; ER stress and MDR; altered protein glycosylation in MDR leukemia
Special Issues, Collections and Topics in MDPI journals
Interests: MDR in leukemia; ABC transporters; ER stress and MDR; altered protein glycosylation in MDR leukemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
There have been several breakthroughs in the treatment of neoplastic diseases, many of which allow curative therapy or significantly reduce the negative effects on patients’ length and quality of life. Cancer chemotherapy is one of the essential therapeutic approaches to effective treatment. Highly active substances have been developed which significantly contribute to the suppression of the development of neoplastic diseases. However, patients may also be non-responders who do not respond to treatment with otherwise effective therapeutics. This is due to a decrease in the sensitivity of neoplastically transformed cells to the drug used. Tumor cells can use several inherent mechanisms to protect them from chemical stress, thus developing a drug-resistant phenotype. A special case of substance resistance is multidrug resistance, in which protective changes in the cellular phenotype provide resistance to different substances with essentially different structure and mechanism of action. Multi-drug resistance often leads to failure of the chemotherapeutic procedure and is known to worsen the prognosis of treatment. In this focused issue, our ambition is to bring together the state-of-the-art information with the possibility of a multilevel insight into the expected further development of knowledge in this topic.
Dr. Zdena Sulová
Prof. Albert Breier
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- multidrug resistance (MDR)
- 1st, 2nd, and 3rd detoxification phases
- escape mechanisms from programmed cell death
- epigenetic changes in MDR
- MDR and ER stress
- MDR and DNA repair
- changes in protein phosphorylation in MDR
- new markers of MDR development
- chemotherapy focused on MDR cancer
- searching for drugs effective in MDR cancer
